Amicus Therapeutics (FOLD) PT Raised to $14 at Cowen on '012 Data
Tweet Send to a Friend
Cowen analyst Ritu Baral reiterated an Outperform rating and boosted his price target on Amicus Therapeutics (NASDAQ: FOLD) to $14.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE